| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |